Delivery Order SPE2DB24D2010-SPE2DB25FZUD5

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,811.68 Firm Fixed Price Delivery Order is for the supply of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, the parent company's Corporate Office division. The award, valued at $1,312.21, is for the delivery of BRIVIACT 100 MG TABLET 60S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of June 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,576.49 firm fixed-price delivery order is for the supply of BRIVIACT 100 MG TABLET 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This federal contract award, valued at $13,295.70, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is a delivery order for the supply of 4,565,946 units of the pharmaceutical product BRIVIACT 25 MG TABLET 60S. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999, which enables the agency to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,673.76 firm fixed price delivery order is for the supply of BRIVIACT 100 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,283.33, is a Firm Fixed Price Delivery Order for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,974.79 firm-fixed-price delivery order is for 60 tablets of the medication BRIVIACT 100 MG. The contract has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $5,283.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a delivery order for the supply of BRIVIACT 50 MG TABLET 60S, a prescription medication. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of BRIVIACT 100 MG TABLET 60S. The $2,557.92 firm fixed-price delivery order contract has an ultimate completion date of November 7, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $1,964.69, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award is for the delivery of BRIVIACT 50MG TAB 60S, a pharmaceutical product, and has an ultimate completion date of July 11, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZUD5
    Delivery Order

This federal contract award, valued at $4,186.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for BRIVIACT 50 MG TABLET 60S and has an ultimate completion date of January 7, 2025. The contract type is Firm Fixed Price.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) since 2002, and it plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 4/7/25, 10:48 AM